We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
After hours: February 12 at 6:10:39 PM EST Loading Chart for DRTS ...
TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...
Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...
After hours: February 13 at 6:40:00 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback